Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Joseph

Showing results (611-620 of 657) with videos related to

Pageof 66
Sort By:
Plos Neglected Tropical Diseases|September 12, 2024
From neglect to equity in snakebite envenoming; what the ICMR-Collaborative Centre of Excellence (CCoE) targetsJaideep C Menon, Bipin Nair, Sanghamitra Pati, et al.
The Journal of Trauma and Acute Care Surgery|May 7, 2019
#EAST4ALL: An introduction to the EAST equity, quality, and inclusion task forceStephanie Bonne, Brian H Williams, Matthew Martin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 27, 2020
Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled TrialK Joseph, L J Vos, Z Gabos, et al.
Plos One|June 8, 2026
Exploring HIV prevention preferences among key populations in Uganda: A qualitative studyMaiya G Block Ngaybe, Kawoya K Joseph, Wadana Hamzazai, et al.
Hypertension (Dallas, Tex. : 1979)|July 25, 2000
Combinations of variations in multiple genes are associated with hypertensionS M Williams, J H Addy, J A Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft modelsDebra Ferguson, Luis E Rodriguez, Joann P Palma, et al.
Psychopharmacology|November 28, 2019
Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [<sup>11</sup>C]-(+)-PHNOMark Slifstein, Anissa Abi-Dargham, Ragy R Girgis, et al.
Mabs|June 24, 2011
Development of an Fn14 agonistic antibody as an anti-tumor agentJennifer S Michaelson, Aldo Amatucci, Rebecca Kelly, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 23, 2003
Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, PeruJ S Mukherjee, J K Joseph, M L Rich, et al.
Anticancer Research|April 13, 2001
Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agentsY Luo, S K Rockow-Magnone, M K Joseph, et al.
Pageof 66

Showing results (611-620 of 657) with videos related to

Sort By:
Pageof 66
Plos Neglected Tropical Diseases|September 12, 2024
From neglect to equity in snakebite envenoming; what the ICMR-Collaborative Centre of Excellence (CCoE) targetsJaideep C Menon, Bipin Nair, Sanghamitra Pati, et al.
The Journal of Trauma and Acute Care Surgery|May 7, 2019
#EAST4ALL: An introduction to the EAST equity, quality, and inclusion task forceStephanie Bonne, Brian H Williams, Matthew Martin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 27, 2020
Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled TrialK Joseph, L J Vos, Z Gabos, et al.
Plos One|June 8, 2026
Exploring HIV prevention preferences among key populations in Uganda: A qualitative studyMaiya G Block Ngaybe, Kawoya K Joseph, Wadana Hamzazai, et al.
Hypertension (Dallas, Tex. : 1979)|July 25, 2000
Combinations of variations in multiple genes are associated with hypertensionS M Williams, J H Addy, J A Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft modelsDebra Ferguson, Luis E Rodriguez, Joann P Palma, et al.
Psychopharmacology|November 28, 2019
Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [<sup>11</sup>C]-(+)-PHNOMark Slifstein, Anissa Abi-Dargham, Ragy R Girgis, et al.
Mabs|June 24, 2011
Development of an Fn14 agonistic antibody as an anti-tumor agentJennifer S Michaelson, Aldo Amatucci, Rebecca Kelly, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 23, 2003
Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, PeruJ S Mukherjee, J K Joseph, M L Rich, et al.
Anticancer Research|April 13, 2001
Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agentsY Luo, S K Rockow-Magnone, M K Joseph, et al.
Pageof 66